Skip to main content

Peer Review reports

From: Durable reduction of Clostridioides difficile infection recurrence and microbiome restoration after treatment with RBX2660: results from an open-label phase 2 clinical trial

Original Submission
11 Oct 2021 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
22 Nov 2021 Reviewed Reviewer Report
3 Dec 2021 Reviewed Reviewer Report
27 Dec 2021 Author responded Author comments - Robert Orenstein
Resubmission - Version 3
27 Dec 2021 Submitted Manuscript version 3
19 Jan 2022 Author responded Author comments - Robert Orenstein
Resubmission - Version 4
19 Jan 2022 Submitted Manuscript version 4
31 Jan 2022 Reviewed Reviewer Report
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
14 Feb 2022 Editorially accepted
12 Mar 2022 Article published 10.1186/s12879-022-07256-y

You can find further information about peer review here.

Back to article page